Hemolytic uremic syndrome (HUS) in adults carries a high morbidity and
mortality, and its cause remains unknown despite many theories. Altho
ugh familial HUS is rare, it affords a unique opportunity to elucidate
underlying mechanisms that mw have relevance to acquired HUS. We have
undertaken a genetic linkage study based on a candidate gene approach
. A common area bounded by the markers D1S212 and D1S306, a distance o
f 26 cM located at 1q32 segregated with the disease (Z max 3.94). We d
emonstrate that the gene for factor II lies within the region. Subsequ
ent mutation analysis of the factor II gene has revealed two mutations
in patients with HUS. In an individual with the sporadic/ relapsing f
orm of the disease we have found a mutation comprising a deletion, sub
sequent frame shift and premature stop codon leading to half normal le
vels of serum factor H. In one of the three families there is a point
mutation in exon 20 causing an arginine to glycine change, which is li
kely to alter structure and hence function of the factor H protein. Fa
ctor H is a major plasma protein that plays a critical regulatory role
in the alternative pathway of complement activation. In light of thes
e findings and previous reports of HUS in patients with factor H defic
iency, we postulate that abnormalities of factor H may be involved in
the etiology of HUS.